Events Sponsored

PLCS 2014- Pharma Legal and Compliance Summit 2014


PCLS

SpicyIP is pleased to announce the 3rd Annual Pharma Legal & Compliance Summit 2014. The details are as follows: The Pharma Legal & Compliance Summit was launched in 2012 and ever since has successfully come up with 2 editions. We now present The 3rd Annual Edition which is to be scheduled for 19th September 2014, Mumbai. The summit brings to you a day of brainstorming sessions with the leaders and veterans of the industry. Addressing the complications and concerns to…


Read More »
Events Sponsored

MAELS 2014- 3rd Annual Media, Advertising and Entertainment Legal Summit


MAELS 2014

SpicyIP is pleased to announce the 3rd Annual Media, Advertising and Entertainment Legal Summit (MAELS 2014). Details are as follows: An aggressive industry research that Lex Witness conducted within the various stakeholders of the industry reflects a lot of ambiguity in the understanding of the current legal & regulatory regime. The 3rd Annual Edition of Media, Advertising &Entertainment Legal Summit 2014 promises to brainstorm on the challenges faced by the Media, Advertising & Entertainment Industry and we shall together look…


Read More »
Copyright

SpicyIP Tidbit: All your content belongs to us (unless you opt out)


Screen Shot 2014-08-22 at 10.35.42 AM

[Update to this post has been made below - regarding a provision in the Copyright Act which may in fact allow this!] Do you know of a copyright provision anywhere in the world that would allow your content (that you created), become an unrelated party’s property unless you sent them an email stating that you’d like to keep your copyright over it? If the letter that our friends over at Medianama received recently are of any indication, Thomson Reuters seems…


Read More »
Drug Regulation Patent

Access to Medicines for Hepatitis C: Part II – Evaluating the Arsenal


prie cut

Gilead’s 300$ a bottle (900$/12 weeks) announcement for blockbuster anti Hepatitis C drug ‘Sovaldi’ comes at a time when Gilead is under tremendous pressure internationally from both governments and civil society organisations to decrease their exorbitant pricing (see here, here and here). In Part I of this post I described developments in India in relation to the drug. In this post I look at the larger picture and situate Gilead’s pricing decisions in the context of targeted advocacy as well as the existence of and…


Read More »
Drug Regulation Patent

Access to Medicines for Hepatitis C: Part I – Gilead Annouces 300$ price for Sovaldi


hep c

After a huge outcry over its exorbitant price, Gilead Science is offering its Hepatitis C (HCV) blockbuster drug ‘Sovaldi’ at a significant discount in India. As the Times of India reports, Sovaldi will now be available at a price of 900$/12 weeks which is roughly 1% of the US price (a whopping 84,000$/12 weeks). This announcement follows earlier accords with Egypt and Doctors Without Borders to sell the drug at this discounted price to low income countries. With an estimated…


Read More »
Copyright

Dandi Salt v. Union of India: Copyright Board may consider Review Applications


Justice Vibhu Bakhru of the Delhi High Court recently passed an order stating that the Registrar of Copyrights does not have the power to adjudicate upon the merits of an application preferred by the Copyright Board, and that the Copyright Board may review its own decisions. The review application was initiated by the petitioners by after their delayed appeal was rejected by the Registrar. You may access the judgment here. Dandi Salt Pvt Ltd v. Union of India and Ors…


Read More »
Others

SpicyIP Weekly Review (10th-17th August, 2014)


spicyip weekly review

The SpicyIP Story of the Week is a guest post by Nehaa Chaudhari on the  Karnataka Goondas Act which seeks to bring within its ambit ‘digital offenders’ and ‘audio or video pirates’. She points out several problems with this development, such as the introduction of Preventive Detention, impact on freedom of speech, and the broad scope of the offences mentioned in the Act. The week began with Rajiv’s post on a lawsuit filed by Vringo against ZTE, Indiamart and Indiamesh…


Read More »
Copyright

Of Posters, Photographs and Poses!


PK poster

Aamir Khan’s upcoming film PK has already become the talk of the town; the actor who was in the news recently for posing nude in one of the posters for the film caught my attention (no pun intended) for a very different reason. It turns out that the poster for PK has been copied from an earlier poster released in 1973 by a Portuguese musician for his music album. In this post, I shall explore the issue of copyrightability of…


Read More »
Biological Diversity Copyright Drug Regulation Patent Trademark Traditional Knowledge

Need Your Feedback: Report on Indian IP and Public Health


A month or so ago, I’d sent around an email to our SpicyIP mailing group asking for inputs on a report on IP and public health (for the WHO India Office). The report (authored by some of the SpicyIP team) deals with patents for the most part, but also contains chapters on trademarks, copyrights and traditional knowledge/biodiversity. The idea was that it would serve as a basic primer for those interested in a quick overview of the key legal issues around…


Read More »
Copyright

Guest Post: Karnataka’s ‘Goondas Act’ – An examination


Many of you may have heard about Karnataka’s new ‘draconian’ Goonda Act which seeks to bring within its ambit ‘digital offenders’ and ‘audio or video pirates’. In this very comprehensive guest post, Nehaa Chaudhari takes a look at this act and points out some severe problems with it. Nehaa is a Nalsar Law graduate. She works on intellectual property/openness law and policy at the Centre for Internet and Society,  New Delhi. [Note: Due to the examination of definitions in the Act, this…


Read More »